Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 4

Effect of caffeic acid phenethyl ester (CAPE) on vascular endothelial growth factor a (VEGF-A) gene expression in gentamicin-induced acute renal nephrotoxicity

Pages
805–809
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that gentamicin decreases VEGF-A gene expression and this might be related to the tissue degeneration at cellular level.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vascular endothelial growth factor-A (VEGF-A) gene expression in an experimental gentamicin-induced nephrotoxicity and ameliorative effect of caffeic acid phenethyl ester (CAPE) was investigated in rats.
📊
Key Findings & Data:Animals were divided into four groups (n=8); control (C) group animals were given 10% dimethylsulfoxide (DMSO); gentamicin (G) group animals were given 100 mg/kg/day gentamicin; CAPE group animals were given 30 mg/kg/day CAPE and CAPE+G group animals were given 100 mg/kg/ day gentamicin plus 30 mg/kg/day CAPE.
💡
Conclusion & Impact:The results showed that gentamicin decreases VEGF-A gene expression and this might be related to the tissue degeneration at cellular level.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Vascular endothelial growth factor-A (VEGF-A) gene expression in an experimental gentamicin-induced nephrotoxicity and ameliorative effect of caffeic acid phenethyl ester (CAPE) was investigated in rats. Animals were divided into four groups (n=8); control (C) group animals were given 10% dimethylsulfoxide (DMSO); gentamicin (G) group animals were given 100 mg/kg/day gentamicin; CAPE group animals were given 30 mg/kg/day CAPE and CAPE+G group animals were given 100 mg/kg/ day gentamicin plus 30 mg/kg/day CAPE. Serum creatinine and BUN levels significantly increased in gentamicin group as compared to the control group (p 0.05). Gene expression level of VEGF-A in gentamicin group significantly decreased as compared to the control group, however, CAPE treatment did not have any increasing effect on the gene expression level. According to histopathological investigation, gentamicin treatment caused prominent degeneration in kidney tissue and CAPE treatment had only slight beneficial effect on lowering the tissue degeneration. The results showed that gentamicin decreases VEGF-A gene expression and this might be related to the tissue degeneration at cellular level. However, CAPE treatment did not have significant ameliorative effect in lowering the gentamicin induced nephrotoxicity.

🔖

Cite This Article

KARACA, Z. M., ÖZEN, H., AKGÖZ, M., ÇİĞREMİŞ, Y. (2018). Effect of caffeic acid phenethyl ester (CAPE) on vascular endothelial growth factor a (VEGF-A) gene expression in gentamicin-induced acute renal nephrotoxicity. Medicine Science, Cilt: 7 - Sayı: 4, 805–809. https://ajindex.com/articles/277613

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lopez-Novoa JM, Quiros Y, Vicente L, et al. New insights into the mechanism of aminoglycoside nephrotoxicity: An integrative point of view. Kidney Int. 2011;79:33-45.
  2. Mazzon E, Britti D, De Sarro A, et al. Effect of n-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2001;424:75-83.
  3. Quiros Y, Vicente-Vicente L, Morales AI, et al. An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci. 2011;119:245-56.
  4. Pedraza-Chaverri J, Maldonado PD, Medina-Campos ON, et al. Garlic ameliorates gentamicin nephrotoxicity: Relation to antioxidant enzymes. Free Radic Biol Med. 2000;29:602-11.
  5. Bello SO, Chika A. Dose-dependent amelioration of gentamicin-induced nephrotoxicity in adult swiss albino rats by vitamin b-complex - a preliminary study. Trop J Pharm Res. 2009;8:111-6. Bhisitkul RB. Vascular endothelial growth factor biology: Clinical implications for ocular treatments. Br J Ophthalmol. 2006;90:1542-7.
  6. Kim BS, Chen J, Weinstein T, et al. Vegf expression in hypoxia and hyperglycemia: Reciprocal effect on branching angiogenesis in epithelialendothelial co-cultures. J Am Soc Nephrol. 2002;13:2027-36.
  7. Lineaweaver WC, Lei MP, Mustain W, et al. Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg. 2004;239:866-73; discussion 73-5.
  8. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (vegf) and its receptors. Faseb J. 1999;13:9-22.
  9. Lin HP, Lin CY, Liu CC, et al. Caffeic acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. Int J Mol Sci. 2013;14:5264-83.
  10. Parlakpinar H, Tasdemir S, Polat A, et al. Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology. 2005;207:169-77.
  11. Ek RO, Serter M, Ergin K, et al. The effects of caffeic acid phenethyl ester (cape) on tnbs-induced colitis in ovariectomized rats. Dig Dis Sci. 2008;53:1609-17.
  12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods. 2001;25:402-8.
  13. Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mrna and protein expression in human kidney. Kidney Int. 1992;42:1457-61.
  14. Eremina V, Baelde HJ, Quaggin SE. Role of the vegf--a signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol. 2007;106:32-7. Kanellis